<DOC>
	<DOCNO>NCT03002558</DOCNO>
	<brief_summary>Objectives : Main objective : To assess impact obstructive sleep apnea ( OSA ) treatment cardiovascular outcome ( morbidity mortality ) patient resistant hypertension ( RH ) . Secondary objective : ) identify subclinical organ damage profile baseline association OSA , identify long term blood pressure control number antihypertensive drug need different depend OSA diagnosis treatment ; ii ) identify epigenetic profile clinical , biological polygraphic variable predictive value cardiovascular outcome RH patient OSA ; iii ) validate HIPARCO-SCORE tool men independent cohort elaborate new tool use woman ; iv ) perform cost-effectiveness analysis evaluate impact OSA diagnosis treatment patient RH . Methodology : Prospective cohort study . 1,371 RH patient recruit . Ambulatory blood pressure monitoring ( ABPM ) , socio-demographic , clinical , OSA-related , biochemical subclinical organ damage variable biological sample baseline collect subject include . A sleep study perform subject study inclusion date . Subsequently , OSA subject manage per local standard practice . Follow-up variable annually collect ( include blood sample ) . On basis OSA treatment , three cohort RH subject define : control ( non-OSA ) , OSA-treated OSA nontreated .</brief_summary>
	<brief_title>Long-term Cardiovascular Outcomes Patients With RH OSA With Without Treatment With CPAP</brief_title>
	<detailed_description>A minimum follow-up 5 year establish . During follow-up , annually programmed visit carry patient , collect variable subject ' interview office.The baseline follow-up variable collect use questionnaire . The variable collect : BP variable ; Anthropometric variable ; Compliance CPAP case CPAP-treated OSA patient ; blood sample extraction ; outcome ( heart disease , cerebrovascular disease , kidney disease , vascular disease ) . All cardiovascular event independently evaluate two doctor establish diagnostic . In case discordance third external doctor ass case . The date event record .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Patients diagnose RH accord follow criterion , include 2 clinical situation : ( ) BP control ABPM ( 24h BP &gt; 130/80 mmHg ) , regardless optimal dose treatment 3 agent ( one must diuretic ) . Other cause inadequate control must discard ( poor compliance , drug ) . ( ii ) Controlled BP treat less 4 medication . Patients age 18 75 year old . To sign informed consent participation study . Secondary hypertension endocrinology cause ( pheochromocytoma , Conn disease , CushingÂ´s Syndrome , hyperparathyroidism ) , drug treatment ( NSAID cortisone , immunodepressants , EPO ) , renal artery stenosis , alcohol abuse , aortic coarctation intracranial tumour . Any process , limit life expectancy le one year . Previously diagnose OSA current active treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Continuous Positive Airway Pressure</keyword>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Cardiovascular Diseases</keyword>
</DOC>